glioma
Glioma Study Unravels Molecular Features of Tumors From Adolescent, Young Adult Patients
Individuals with low-grade tumors and pediatric glioma-like alterations tended to have better progression-free survival and overall outcomes than others.
Pediatric Brain Cancer Study Yields Prognostic Clues Tied to T-Cell Receptor Features
Researchers profiled T-cell receptors in pediatric brain tumors to identify prognostic T-cell expansion patterns and tumor antigens targeted by tumor-infiltrating lymphocytes.
Foundation Medicine Assay Nabs FDA Approval as CDx for Ojemda in Pediatric Patients
The FoundationOne test can be used to identify patients with relapsed or refractory BRAF-altered pediatric low-grade glioma who may be eligible for therapeutic options.
Brain Cancer Study Reveals Immune Cell Populations Linked to Aggressive Subtype
Researchers used single-cell RNA sequencing and spatial transcriptomics to find two myeloid-derived suppressor cell subsets supporting the growth of an aggressive glioblastoma.
FDA Approves Thermo Fisher Oncomine Dx Target Test as CDx for Servier's Voranigo Brain Cancer Drug
The approval expands the clinical indications for the test, which was previously approved as a CDx for non-small cell lung cancer, thyroid cancer, and bile duct cancer drugs.